For reprint rights or to purchase a copy of your Daily Journal photo, email Jeremy_Ellis@dailyjournal.com for prices or call 213-229-5424.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...
You have to be a subscriber to view this page.

Mergers & Acquisitions

Jul. 10, 2015

Newark drugmaker rejects rival's takeover overtures

The wave of consolidation currently sweeping the pharmacecutical industry crested over California again this week with the news that Horizon Pharma PLC had put forward a $3 billion unsolicited buyout offer for its smaller rival, Depomed Inc.


By Melanie Brisbon


Daily Journal Staff Writer


Dublin, Ireland-based Horizon Pharma PLC has made a $3 billion unsolicited buyout
offer for Depomed Inc., a smaller rival based in Newark that makes pain treatments.


The offer, which is already meeting resistance from Depomed's board, is just the last
in a wave of mergers in the sector this year, as pharmaceutical compani...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.